APA (7th ed.) Citation

N, C., M, M., P, S., M, R., S, K., O, H., . . . EM, S. (2025). A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast cancer research and treatment, 211(1), 111. https://doi.org/10.1007/s10549-025-07626-5

Chicago Style (17th ed.) Citation

N, Chen, et al. "A Randomized Phase II Trial of Nab-paclitaxel with or Without Mifepristone for Advanced Triple-negative Breast Cancer." Breast Cancer Research and Treatment 211, no. 1 (2025): 111. https://doi.org/10.1007/s10549-025-07626-5.

MLA (9th ed.) Citation

N, Chen, et al. "A Randomized Phase II Trial of Nab-paclitaxel with or Without Mifepristone for Advanced Triple-negative Breast Cancer." Breast Cancer Research and Treatment, vol. 211, no. 1, 2025, p. 111, https://doi.org/10.1007/s10549-025-07626-5.